サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1120469

世界の帯状疱疹感染症治療薬市場：考察と予測 (2028年まで)

Global Herpes Zoster Infection Treatment Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 109 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の帯状疱疹感染症治療薬市場：考察と予測 (2028年まで)
出版日: 2022年08月30日
発行: QYResearch
ページ情報: 英文 109 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、帯状疱疹感染症治療薬 (Herpes Zoster Infection Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の帯状疱疹感染症治療薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Oral
    • Topical
  • 市場：アプリケーション別
    • 世界の帯状疱疹感染症治療薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Clinics
    • Hospitals
    • Diagnostic centers
    • Home Care
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の帯状疱疹感染症治療薬の市場展望 (2017-2028)
  • 帯状疱疹感染症治療薬の市場成長トレンド：地域別
    • 帯状疱疹感染症治療薬 市場規模：地域別: 2017 VS 2021 VS 2028
    • 帯状疱疹感染症治療薬の市場規模実績：地域別 (2017-2022)
    • 帯状疱疹感染症治療薬の市場規模予測：地域別 (2023-2028)
  • 帯状疱疹感染症治療薬 市場動向
    • 帯状疱疹感染症治療薬 業界動向
    • 帯状疱疹感染症治療薬 市場の促進要因
    • 帯状疱疹感染症治療薬 市場の課題
    • 帯状疱疹感染症治療薬 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の帯状疱疹感染症治療薬の上位企業：収益別
    • 世界の帯状疱疹感染症治療薬の上位企業：収益別 (2017-2022)
    • 世界の帯状疱疹感染症治療薬の収益シェア：企業別 (2017-2022)
  • 世界の帯状疱疹感染症治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：帯状疱疹感染症治療薬の収益
  • 世界の帯状疱疹感染症治療薬 市場集中度
    • 世界の帯状疱疹感染症治療薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 帯状疱疹感染症治療薬の収益 2021
  • 帯状疱疹感染症治療薬の主要企業の本社および事業エリア
  • 主要企業 帯状疱疹感染症治療薬の製品ソリューションおよびサービス
  • 市場参入時期： 帯状疱疹感染症治療薬 市場
  • M&A, 拡張計画

第4章 帯状疱疹感染症治療薬 内訳データ：タイプ別

  • 世界の帯状疱疹感染症治療薬の市場規模実績：タイプ別 (2017-2022)
  • 世界の帯状疱疹感染症治療薬の市場規模予測：タイプ別 (2023-2028)

第5章 帯状疱疹感染症治療薬 内訳データ：アプリケーション別

  • 世界の帯状疱疹感染症治療薬の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の帯状疱疹感染症治療薬の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の帯状疱疹感染症治療薬 市場規模 (2017-2028)
  • 北米の帯状疱疹感染症治療薬 市場規模：タイプ別
    • 北米の帯状疱疹感染症治療薬 市場規模：タイプ別 (2017-2022)
    • 北米の帯状疱疹感染症治療薬 市場規模：タイプ別 (2023-2028)
    • 北米の帯状疱疹感染症治療薬の市場シェア：タイプ別 (2017-2028)
  • 北米の帯状疱疹感染症治療薬 市場規模：アプリケーション別
    • 北米の帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2017-2022)
    • 北米の帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2023-2028)
    • 北米の帯状疱疹感染症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 北米の帯状疱疹感染症治療薬 市場規模：国別
    • 北米の帯状疱疹感染症治療薬 市場規模：国別 (2017-2022)
    • 北米の帯状疱疹感染症治療薬 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の帯状疱疹感染症治療薬 市場規模 (2017-2028)
  • 欧州の帯状疱疹感染症治療薬 市場規模：タイプ別
    • 欧州の帯状疱疹感染症治療薬 市場規模：タイプ別 (2017-2022)
    • 欧州の帯状疱疹感染症治療薬 市場規模：タイプ別 (2023-2028)
    • 欧州の帯状疱疹感染症治療薬の市場シェア：タイプ別 (2017-2028)
  • 欧州の帯状疱疹感染症治療薬 市場規模：アプリケーション別
    • 欧州の帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2017-2022)
    • 欧州の帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2023-2028)
    • 欧州の帯状疱疹感染症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の帯状疱疹感染症治療薬 市場規模：国別
    • 欧州の帯状疱疹感染症治療薬 市場規模：国別 (2017-2022)
    • 欧州の帯状疱疹感染症治療薬 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模 (2017-2028)
  • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：タイプ別
    • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 帯状疱疹感染症治療薬の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：アプリケーション別
    • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 帯状疱疹感染症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：地域別
    • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 帯状疱疹感染症治療薬 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの帯状疱疹感染症治療薬 市場規模 (2017-2028)
  • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：タイプ別
    • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの帯状疱疹感染症治療薬の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：アプリケーション別
    • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの帯状疱疹感染症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：国別
    • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：国別 (2017-2022)
    • ラテンアメリカの帯状疱疹感染症治療薬 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの帯状疱疹感染症治療薬 市場規模 (2017-2028)
  • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：タイプ別
    • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの帯状疱疹感染症治療薬の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：アプリケーション別
    • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの帯状疱疹感染症治療薬の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：国別
    • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：国別 (2017-2022)
    • 中東・アフリカの帯状疱疹感染症治療薬 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Bausch Health
  • Camber Pharmaceuticals
  • Novartis
  • Teva Pharmaceutical
  • Abbott
  • Merck

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Oral
  • Table 3. Key Players of Topical
  • Table 4. Global Herpes Zoster Infection Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Herpes Zoster Infection Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Herpes Zoster Infection Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Herpes Zoster Infection Treatment Market Share by Region (2017-2022)
  • Table 8. Global Herpes Zoster Infection Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Herpes Zoster Infection Treatment Market Share by Region (2023-2028)
  • Table 10. Herpes Zoster Infection Treatment Market Trends
  • Table 11. Herpes Zoster Infection Treatment Market Drivers
  • Table 12. Herpes Zoster Infection Treatment Market Challenges
  • Table 13. Herpes Zoster Infection Treatment Market Restraints
  • Table 14. Global Herpes Zoster Infection Treatment Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Herpes Zoster Infection Treatment Revenue Share by Players (2017-2022)
  • Table 16. Global Top Herpes Zoster Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoster Infection Treatment as of 2021)
  • Table 17. Ranking of Global Top Herpes Zoster Infection Treatment Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Herpes Zoster Infection Treatment Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Herpes Zoster Infection Treatment Product Solution and Service
  • Table 21. Date of Enter into Herpes Zoster Infection Treatment Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Herpes Zoster Infection Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2017-2022)
  • Table 25. Global Herpes Zoster Infection Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2023-2028)
  • Table 27. Global Herpes Zoster Infection Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Herpes Zoster Infection Treatment Revenue Share by Application (2017-2022)
  • Table 29. Global Herpes Zoster Infection Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Herpes Zoster Infection Treatment Revenue Share by Application (2023-2028)
  • Table 31. North America Herpes Zoster Infection Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Herpes Zoster Infection Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Herpes Zoster Infection Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Herpes Zoster Infection Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Herpes Zoster Infection Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Herpes Zoster Infection Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Herpes Zoster Infection Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Herpes Zoster Infection Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Herpes Zoster Infection Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Herpes Zoster Infection Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Herpes Zoster Infection Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Herpes Zoster Infection Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Herpes Zoster Infection Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Herpes Zoster Infection Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Herpes Zoster Infection Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Herpes Zoster Infection Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Herpes Zoster Infection Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Herpes Zoster Infection Treatment Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Herpes Zoster Infection Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Herpes Zoster Infection Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Herpes Zoster Infection Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Herpes Zoster Infection Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Herpes Zoster Infection Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Herpes Zoster Infection Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Herpes Zoster Infection Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Herpes Zoster Infection Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Herpes Zoster Infection Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Herpes Zoster Infection Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Herpes Zoster Infection Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Herpes Zoster Infection Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Bausch Health Company Details
  • Table 62. Bausch Health Business Overview
  • Table 63. Bausch Health Herpes Zoster Infection Treatment Product
  • Table 64. Bausch Health Revenue in Herpes Zoster Infection Treatment Business (2017-2022) & (US$ Million)
  • Table 65. Bausch Health Recent Developments
  • Table 66. Camber Pharmaceuticals Company Details
  • Table 67. Camber Pharmaceuticals Business Overview
  • Table 68. Camber Pharmaceuticals Herpes Zoster Infection Treatment Product
  • Table 69. Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2017-2022) & (US$ Million)
  • Table 70. Camber Pharmaceuticals Recent Developments
  • Table 71. Novartis Company Details
  • Table 72. Novartis Business Overview
  • Table 73. Novartis Herpes Zoster Infection Treatment Product
  • Table 74. Novartis Revenue in Herpes Zoster Infection Treatment Business (2017-2022) & (US$ Million)
  • Table 75. Novartis Recent Developments
  • Table 76. Teva Pharmaceutical Company Details
  • Table 77. Teva Pharmaceutical Business Overview
  • Table 78. Teva Pharmaceutical Herpes Zoster Infection Treatment Product
  • Table 79. Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2017-2022) & (US$ Million)
  • Table 80. Teva Pharmaceutical Recent Developments
  • Table 81. Abbott Company Details
  • Table 82. Abbott Business Overview
  • Table 83. Abbott Herpes Zoster Infection Treatment Product
  • Table 84. Abbott Revenue in Herpes Zoster Infection Treatment Business (2017-2022) & (US$ Million)
  • Table 85. Abbott Recent Developments
  • Table 86. Merck Company Details
  • Table 87. Merck Business Overview
  • Table 88. Merck Herpes Zoster Infection Treatment Product
  • Table 89. Merck Revenue in Herpes Zoster Infection Treatment Business (2017-2022) & (US$ Million)
  • Table 90. Merck Recent Developments
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Herpes Zoster Infection Treatment Market Share by Type: 2021 VS 2028
  • Figure 2. Oral Features
  • Figure 3. Topical Features
  • Figure 4. Global Herpes Zoster Infection Treatment Market Share by Application: 2021 VS 2028
  • Figure 5. Clinics Case Studies
  • Figure 6. Hospitals Case Studies
  • Figure 7. Diagnostic centers Case Studies
  • Figure 8. Home Care Case Studies
  • Figure 9. Herpes Zoster Infection Treatment Report Years Considered
  • Figure 10. Global Herpes Zoster Infection Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Herpes Zoster Infection Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Herpes Zoster Infection Treatment Market Share by Region: 2021 VS 2028
  • Figure 13. Global Herpes Zoster Infection Treatment Market Share by Players in 2021
  • Figure 14. Global Top Herpes Zoster Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Zoster Infection Treatment as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Herpes Zoster Infection Treatment Revenue in 2021
  • Figure 16. North America Herpes Zoster Infection Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Herpes Zoster Infection Treatment Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Herpes Zoster Infection Treatment Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Herpes Zoster Infection Treatment Market Size Share by Country (2017-2028)
  • Figure 20. United States Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Herpes Zoster Infection Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Herpes Zoster Infection Treatment Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Herpes Zoster Infection Treatment Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Herpes Zoster Infection Treatment Market Size Share by Country (2017-2028)
  • Figure 26. Germany Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Herpes Zoster Infection Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Herpes Zoster Infection Treatment Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Herpes Zoster Infection Treatment Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Herpes Zoster Infection Treatment Market Size Share by Region (2017-2028)
  • Figure 36. China Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Herpes Zoster Infection Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Herpes Zoster Infection Treatment Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Herpes Zoster Infection Treatment Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Herpes Zoster Infection Treatment Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Herpes Zoster Infection Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Herpes Zoster Infection Treatment Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Herpes Zoster Infection Treatment Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Herpes Zoster Infection Treatment Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Herpes Zoster Infection Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Bausch Health Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2017-2022)
  • Figure 56. Camber Pharmaceuticals Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2017-2022)
  • Figure 57. Novartis Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2017-2022)
  • Figure 58. Teva Pharmaceutical Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2017-2022)
  • Figure 59. Abbott Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2017-2022)
  • Figure 60. Merck Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2017-2022)
  • Figure 61. Bottom-up and Top-down Approaches for This Report
  • Figure 62. Data Triangulation
  • Figure 63. Key Executives Interviewed
目次

This research report focuses on the Herpes Zoster Infection Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Oral
    • 1.2.3 Topical
  • 1.3 Market by Application
    • 1.3.1 Global Herpes Zoster Infection Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Clinics
    • 1.3.3 Hospitals
    • 1.3.4 Diagnostic centers
    • 1.3.5 Home Care
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Herpes Zoster Infection Treatment Market Perspective (2017-2028)
  • 2.2 Herpes Zoster Infection Treatment Growth Trends by Region
    • 2.2.1 Herpes Zoster Infection Treatment Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Herpes Zoster Infection Treatment Historic Market Size by Region (2017-2022)
    • 2.2.3 Herpes Zoster Infection Treatment Forecasted Market Size by Region (2023-2028)
  • 2.3 Herpes Zoster Infection Treatment Market Dynamics
    • 2.3.1 Herpes Zoster Infection Treatment Industry Trends
    • 2.3.2 Herpes Zoster Infection Treatment Market Drivers
    • 2.3.3 Herpes Zoster Infection Treatment Market Challenges
    • 2.3.4 Herpes Zoster Infection Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Herpes Zoster Infection Treatment Players by Revenue
    • 3.1.1 Global Top Herpes Zoster Infection Treatment Players by Revenue (2017-2022)
    • 3.1.2 Global Herpes Zoster Infection Treatment Revenue Market Share by Players (2017-2022)
  • 3.2 Global Herpes Zoster Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Herpes Zoster Infection Treatment Revenue
  • 3.4 Global Herpes Zoster Infection Treatment Market Concentration Ratio
    • 3.4.1 Global Herpes Zoster Infection Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Herpes Zoster Infection Treatment Revenue in 2021
  • 3.5 Herpes Zoster Infection Treatment Key Players Head office and Area Served
  • 3.6 Key Players Herpes Zoster Infection Treatment Product Solution and Service
  • 3.7 Date of Enter into Herpes Zoster Infection Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Herpes Zoster Infection Treatment Breakdown Data by Type

  • 4.1 Global Herpes Zoster Infection Treatment Historic Market Size by Type (2017-2022)
  • 4.2 Global Herpes Zoster Infection Treatment Forecasted Market Size by Type (2023-2028)

5 Herpes Zoster Infection Treatment Breakdown Data by Application

  • 5.1 Global Herpes Zoster Infection Treatment Historic Market Size by Application (2017-2022)
  • 5.2 Global Herpes Zoster Infection Treatment Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Herpes Zoster Infection Treatment Market Size (2017-2028)
  • 6.2 North America Herpes Zoster Infection Treatment Market Size by Type
    • 6.2.1 North America Herpes Zoster Infection Treatment Market Size by Type (2017-2022)
    • 6.2.2 North America Herpes Zoster Infection Treatment Market Size by Type (2023-2028)
    • 6.2.3 North America Herpes Zoster Infection Treatment Market Share by Type (2017-2028)
  • 6.3 North America Herpes Zoster Infection Treatment Market Size by Application
    • 6.3.1 North America Herpes Zoster Infection Treatment Market Size by Application (2017-2022)
    • 6.3.2 North America Herpes Zoster Infection Treatment Market Size by Application (2023-2028)
    • 6.3.3 North America Herpes Zoster Infection Treatment Market Share by Application (2017-2028)
  • 6.4 North America Herpes Zoster Infection Treatment Market Size by Country
    • 6.4.1 North America Herpes Zoster Infection Treatment Market Size by Country (2017-2022)
    • 6.4.2 North America Herpes Zoster Infection Treatment Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Herpes Zoster Infection Treatment Market Size (2017-2028)
  • 7.2 Europe Herpes Zoster Infection Treatment Market Size by Type
    • 7.2.1 Europe Herpes Zoster Infection Treatment Market Size by Type (2017-2022)
    • 7.2.2 Europe Herpes Zoster Infection Treatment Market Size by Type (2023-2028)
    • 7.2.3 Europe Herpes Zoster Infection Treatment Market Share by Type (2017-2028)
  • 7.3 Europe Herpes Zoster Infection Treatment Market Size by Application
    • 7.3.1 Europe Herpes Zoster Infection Treatment Market Size by Application (2017-2022)
    • 7.3.2 Europe Herpes Zoster Infection Treatment Market Size by Application (2023-2028)
    • 7.3.3 Europe Herpes Zoster Infection Treatment Market Share by Application (2017-2028)
  • 7.4 Europe Herpes Zoster Infection Treatment Market Size by Country
    • 7.4.1 Europe Herpes Zoster Infection Treatment Market Size by Country (2017-2022)
    • 7.4.2 Europe Herpes Zoster Infection Treatment Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size (2017-2028)
  • 8.2 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Herpes Zoster Infection Treatment Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Herpes Zoster Infection Treatment Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Herpes Zoster Infection Treatment Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Herpes Zoster Infection Treatment Market Size (2017-2028)
  • 9.2 Latin America Herpes Zoster Infection Treatment Market Size by Type
    • 9.2.1 Latin America Herpes Zoster Infection Treatment Market Size by Type (2017-2022)
    • 9.2.2 Latin America Herpes Zoster Infection Treatment Market Size by Type (2023-2028)
    • 9.2.3 Latin America Herpes Zoster Infection Treatment Market Share by Type (2017-2028)
  • 9.3 Latin America Herpes Zoster Infection Treatment Market Size by Application
    • 9.3.1 Latin America Herpes Zoster Infection Treatment Market Size by Application (2017-2022)
    • 9.3.2 Latin America Herpes Zoster Infection Treatment Market Size by Application (2023-2028)
    • 9.3.3 Latin America Herpes Zoster Infection Treatment Market Share by Application (2017-2028)
  • 9.4 Latin America Herpes Zoster Infection Treatment Market Size by Country
    • 9.4.1 Latin America Herpes Zoster Infection Treatment Market Size by Country (2017-2022)
    • 9.4.2 Latin America Herpes Zoster Infection Treatment Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size (2017-2028)
  • 10.2 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Herpes Zoster Infection Treatment Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Herpes Zoster Infection Treatment Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Herpes Zoster Infection Treatment Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bausch Health
    • 11.1.1 Bausch Health Company Details
    • 11.1.2 Bausch Health Business Overview
    • 11.1.3 Bausch Health Herpes Zoster Infection Treatment Introduction
    • 11.1.4 Bausch Health Revenue in Herpes Zoster Infection Treatment Business (2017-2022)
    • 11.1.5 Bausch Health Recent Developments
  • 11.2 Camber Pharmaceuticals
    • 11.2.1 Camber Pharmaceuticals Company Details
    • 11.2.2 Camber Pharmaceuticals Business Overview
    • 11.2.3 Camber Pharmaceuticals Herpes Zoster Infection Treatment Introduction
    • 11.2.4 Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2017-2022)
    • 11.2.5 Camber Pharmaceuticals Recent Developments
  • 11.3 Novartis
    • 11.3.1 Novartis Company Details
    • 11.3.2 Novartis Business Overview
    • 11.3.3 Novartis Herpes Zoster Infection Treatment Introduction
    • 11.3.4 Novartis Revenue in Herpes Zoster Infection Treatment Business (2017-2022)
    • 11.3.5 Novartis Recent Developments
  • 11.4 Teva Pharmaceutical
    • 11.4.1 Teva Pharmaceutical Company Details
    • 11.4.2 Teva Pharmaceutical Business Overview
    • 11.4.3 Teva Pharmaceutical Herpes Zoster Infection Treatment Introduction
    • 11.4.4 Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2017-2022)
    • 11.4.5 Teva Pharmaceutical Recent Developments
  • 11.5 Abbott
    • 11.5.1 Abbott Company Details
    • 11.5.2 Abbott Business Overview
    • 11.5.3 Abbott Herpes Zoster Infection Treatment Introduction
    • 11.5.4 Abbott Revenue in Herpes Zoster Infection Treatment Business (2017-2022)
    • 11.5.5 Abbott Recent Developments
  • 11.6 Merck
    • 11.6.1 Merck Company Details
    • 11.6.2 Merck Business Overview
    • 11.6.3 Merck Herpes Zoster Infection Treatment Introduction
    • 11.6.4 Merck Revenue in Herpes Zoster Infection Treatment Business (2017-2022)
    • 11.6.5 Merck Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer